Beaumont Financial Advisors’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,000
Closed -$7.47K 355
2023
Q2
$7.47K Buy
18,000
+16,500
+1,100% +$115K ﹤0.01% 343
2023
Q1
$7.47K Hold
1,500
﹤0.01% 316
2022
Q4
$7.25K Sell
1,500
-2,500
-63% -$12.3K ﹤0.01% 314
2022
Q3
$41K Hold
4,000
﹤0.01% 301
2022
Q2
$56K Hold
4,000
0.01% 303
2022
Q1
$68K Hold
4,000
0.01% 354
2021
Q4
$98K Hold
4,000
0.01% 348
2021
Q3
$148K Buy
4,000
+1,667
+71% +$61.2K 0.01% 350
2021
Q2
$114K Buy
2,333
+833
+56% +$34.7K 0.01% 362
2021
Q1
$44K Hold
1,500
﹤0.01% 336
2020
Q4
$38K Hold
1,500
﹤0.01% 330
2020
Q3
$22K Hold
1,500
﹤0.01% 307
2020
Q2
$31K Hold
1,500
﹤0.01% 276
2020
Q1
$48K Hold
1,500
0.01% 230
2019
Q4
$24K Hold
1,500
﹤0.01% 280
2019
Q3
$22K Hold
1,500
﹤0.01% 270
2019
Q2
$27K Hold
1,500
﹤0.01% 246
2019
Q1
$53K Hold
1,500
0.01% 229
2018
Q4
$60K Hold
1,500
0.01% 195
2018
Q3
$131K Hold
1,500
0.01% 225
2018
Q2
$124K Hold
1,500
0.01% 201
2018
Q1
$54K Buy
1,500
+667
+80% +$25.8K 0.01% 205
2017
Q4
$31K Hold
833
﹤0.01% 188
2017
Q3
$47K Hold
833
0.01% 182
2017
Q2
$22K Buy
+833
New +$21.2K ﹤0.01% 176

Other funds holding VSTM

Beaumont Financial Advisors's VSTM Position: Q3 2023 in Review

Beaumont Financial Advisors sold out of Verastem (VSTM) in Q3 2023, closing a stake of 18,000 shares — an estimated $7.47K sold.

Beaumont Financial Advisors first reported a position in VSTM in Q2 2017 and held it in 25 quarters. The position peaked at $148K in Q3 2021. 57 funds tracked by Wall St. Rank hold VSTM as of Q3 2023.

  • Beaumont Financial Advisors reported no remaining Verastem position as of Q3 2023 after selling out during the quarter.
  • Beaumont Financial Advisors sold 18,000 Verastem shares in Q3 2023, an estimated $7.47K.
  • Beaumont Financial Advisors first reported a position in Verastem in Q2 2017 and held it in 25 quarters.
  • Beaumont Financial Advisors's Verastem position peaked at $148K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Verastem as of Q3 2023.

Based on Beaumont Financial Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.